JESSICA AL KHALIDI: Open Payments
NPI 1760143275 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,435 in 65 payments from 16 companies in 2025. Trend: 2023 $1,720 · 2024 $1,933 · 2025 $1,435
Food & beverage: $1,335Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $333 |
| ABBVIE INC. | 10 | $201 |
| Ardelyx, Inc. | 4 | $138 |
| Celltrion USA Inc. | 5 | $107 |
| Lilly USA, LLC | 5 | $103 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $76 |
| Madrigal Pharmaceuticals | 3 | $74 |
| Ipsen Biopharmaceuticals, Inc | 3 | $71 |
| PFIZER INC. | 4 | $69 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $56 |
Products named: TREMFYA, IBSRELA, LINZESS, VEGZELMA, OMVOH, EOHILIA, REZDIFFRA, IQIRVO.
Industry payments across TX — which companies pay providers there.
